the cost-effectiveness of endovascular therapy for patients with acute ischemic stroke
-
- Ryu Matsuo
- Principal Investigator
- 九州大学
-
- 福田 治久
- Co-Investigator
- 九州大学
-
- 北園 孝成
- Co-Investigator
- 九州大学
-
- 鴨打 正浩
- Co-Investigator
- 九州大学
About this project
- Japan Grant Number
- JP18K09944
- Funding Program
- Grants-in-Aid for Scientific Research
- Funding organization
- Japan Society for the Promotion of Science
- Project/Area Number
- 18K09944
- Research Category
- Grant-in-Aid for Scientific Research (C)
- Allocation Type
-
- Multi-year Fund
- Review Section / Research Field
-
- Basic Section 58010:Medical management and medical sociology-related
- Research Institution
-
- Kyushu University
- Project Period (FY)
- 2018-04-01 〜 2024-03-31
- Project Status
- Completed
- Budget Amount*help
- 4,420,000 Yen (Direct Cost: 3,400,000 Yen Indirect Cost: 1,020,000 Yen)
Research Abstract
In this study, we evaluated the cost-effectiveness of endovascular therapy (EVT) for patients with acute ischemic stroke using data from a cohort study, Fukuoka Stroke Registry, in Japan. Effectiveness was measured in quality-adjusted life years (QALYs) calculated from the modified Rankin Scale (mRS) over one year post-onset. Costs included total hospitalization expenses and the estimated annual caregiving costs based on the mRS at one year after stroke. The incremental cost-effectiveness ratio (ICER) of EVT was 7.94 million yen, exceeding Japan’s commonly cited cost-effectiveness threshold of 5 million yen. These findings suggested that the cost-effectiveness of EVT in a real-world setting may not be favorable in the short term.
